All In MedTech

Device Trial Radar · NCT03436979

The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse

The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Post-Market Surveillance Clinical Study

Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Jan 1, 2018

Primary completion

Oct 31, 2023

Study completion Oct 31, 2023

Sponsor

Lead sponsor
Pop Medical SolutionsNot on our public-company list
Sponsor type
Industry
First posted
Feb 19, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 36 years, up to 84 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.

Conditions

  • Uterine Prolapse Without Vaginal Wall Prolapse

Interventions

  • NeuGuide™ SystemDevice

    The NeuGuide™ device is indicated for anchoring sutures to ligaments of the pelvic floor.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A composite of the Pelvic Organ Prolapse Quantification (POP-Q) C point score, patient-rated symptom of vaginal bulging after vaginal colpopexy performed using the NeuGuide™ and the absence of further surgical therapy for uterine prolapse.Time frame: 12 months

2 more outcomes with a free account

Locations

15 sites in 3 countries. Site status is shown where the registry gives one.

  • MedStar Health Research Institute

    Washington D.C., District of Columbia

14 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.